Drug-induced Liver Injury from Intravenous Immunoglobulin for Prevention of Recurrent Gestational Alloimmune Liver Disease: A Clinical Catch-22

Ítems similars

• Neonatal Hemochromatosis: Treatment with Exchange Transfusion and Intravenous Immunoglobulin
  per: Ehab Mohamed Hantash, et al.
  Publicat: (2021-07-01)
• Premature birth associated with a favorable course in gestational alloimmune liver disease (GALD): A case report
  per: Linda-Marie Mulzer, et al.
  Publicat: (2023-03-01)
• Double-Filtration Plasmapheresis and High-Dose Intravenous Immunoglobulin Therapy in a Case of Anti-M Alloimmunization
  per: Shun Yasuda, et al.
  Publicat: (2024-04-01)
• Improving prediction of fetal/neonatal intracranial hemorrhage in HPA‐1a alloimmunized pregnancies to guide antenatal management: An observational cohort study
  per: Siw Leiknes Ernstsen, et al.
  Publicat: (2025-10-01)
• Drug-induced Liver Injury from Intravenous Immunoglobulin for Prevention of Recurrent Gestational Alloimmune Liver Disease: A Clinical Catch-22
  per: Jessica A. Meyer, et al.
  Publicat: (2024-07-01)